Investor's Business Daily on MSN

Why IBD Stock Of The Day Medpace, Up 78% In 2025, Is Easily Outpacing Its Peers

Medpace is Tuesday's IBD Stock Of The Day. After a "staggering beat-and-raise quarter," Medpace stock has traded tightly for ...
University of California, San Francisco

New Healthy, Hopeful, Care Guidelines for Pregnant Women with IBD

Women with inflammatory bowel disease (IBD) face increased pregnancy risks, often leading to confusion and fear. UCSF’s PIANO ...

Chromologics raises €7 million to bring its natural colour ingredients closer to market

Chromologics, a Danish biotech company developing fermentation-based natural colours, has raised €7 million from Novo Holdings, EIFO ...

European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab

Celltrion, Inc. today announced that the European Commission (EC) has granted marketing authorization for Remsima™ IV ...